Company Overview of CG Therapeutics, Inc.
CG Therapeutics, Inc., a biotechnology company, develops human chorionic gonadotropin (hCG)-targeted cancer immunotherapeutic products. Its products include CG201, an anti-hCG vaccine, which targets hCG-producing tumors by stimulating patients’ immune systems to produce antibodies that eliminate hCG; and anti-hCG monoclonal antibodies, which are developed for therapeutic applications for treating cancer in combination with CG201. The company serves government agencies, universities, and corporations. CG Therapeutics was founded in 2005 and is based in Seattle, Washington.
2815 Eastlake Avenue East
Seattle, WA 98102
Founded in 2005
Key Executives for CG Therapeutics, Inc.
Similar Private Companies By Industry
|MorepenMax Inc||United States|
|Purdue Pharma Company, The||United States|
|Symphony GenIsis Inc.||United States|
|Applied Laboratories, Inc.||United States|
|InVasc Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Summit, NJ | DiversantPosted: Jul 03
- Fort Lauderdale, FL | Broward HealthPosted: Dec 16
- Brown Deer, WI | Kelly Scientific ResourcesPosted: Dec 13
- Spring House, PA | Johnson & JohnsonPosted: Dec 17
Sponsored Financial Commentaries
To contact CG Therapeutics, Inc., please visit www.cgtherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.